Trump Promised Cheaper Drugs: Some Prices Fall, Others Jump
As of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...
This intro covers zero-fee index funds available in 2024, helping you compare costs and identify cost-efficient options for long-term investing.
15,531 articlesAs of May 7, 2026, Trump’s drug-pricing drive shows a mixed outcome: some medicines price cuts, but many others highe...
Chip stocks are rising on AI infrastructure strength even as software names sag, hinting at a broader market rotation...
High-income investors face a tax cliff with JEPI: the 8% distribution yield is largely ordinary income, trimming real...
As Trump meets with Xi, the U.S.-China relationship enters a peer-level phase. Security experts warn Beijing now sees...
Markets ride to new highs while anxiety hits home for many investors paralyzed right now. This report explains why an...
When a top investor takes a sizable stake in a marquee stock, it grabs attention. This piece breaks down what billion...
A fresh look at history shows disciplined buyers beat market timers over lengthy, stagnant periods. The counterintuit...
The AI boom isn’t over. If you felt you missed the first wave, these three resilient stocks deliver real AI leverage,...
Looking a decade ahead, two large, resilient shares stand out. This article explains why NVIDIA and Microsoft are pri...
Investors are split as talks on a possible Iran accord fuel optimism and a warning that the iran deal could actually ...
A 24-year-old youth pastor questions whether retirement is feasible on a $2,000 monthly income. Experts urge prioriti...
May's initial jobless claims rose to a four-month high, but the spike is tied to Memorial Day timing rather than a br...